WebOct 19, 2024 · Solithromycin (SOL), a fourth-generation macrolide and ketolide, has been reported to have robust antibacterial activity against a wide spectrum of Gram-positive … WebGonorrhea may become untreatable, and new treatment options are essential. We investigated the in vitro activity of the first fluoroketolide, solithromycin. Clinical Neisseria …
Cempra gets $10M milestone for its antibiotic development in Japan
WebAug 28, 2024 · Solithromycin (T 4288) is a fourth generation fluoroketolide (macrolide) antibacterial agent, ... 25 Apr 2024 Preregistration for Otorhinolaryngological infections in … WebMar 28, 2024 · Solithromycin is licensed to strategic commercial partner Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings Corporation, for certain exclusive rights in … tsj chihuahua directorio
Azithromycin resistant gonococci: a literature review
WebJun 15, 2024 · Solithromycin is a novel ketolide antibiotic with activity against a broad spectrum of intracellular organisms, including those displaying macrolide resistance. While demonstrating noninferiority to a current first-line agent in the treatment of CABP, concerns for drug-induced liver injury and infus … WebAug 18, 2024 · Shigemura and his research team in Japan likewise reported that a deletion mutation of the mtrR promoter region is a possible mechanism of ... Golden M, Jamieson … WebJun 19, 2015 · Drug Overview. Solithromycin (Cempra Pharmaceuticals/Cubist Pharmaceuticals/Toyama Chemical) is a next-generation ketolide antibiotic. The drug, … t s j contracting llc dubai